Opioid overdoses involving xylazine in emergency department patients: a multicenter study

References

• Green TC, Gilbert M. Counterfeit medications and fentanyl. JAMA Intern Med. 2016;176(10):1555–1557.
   PubMed Web of Science ®Google Scholar
• Macmadu A, Carroll JJ, Hadland SE, et al. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35–38.
   PubMed Web of Science ®Google Scholar
• Jones CM, Einstein EB, Compton WM. Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010–2016. JAMA. 2018;319(17):1819–1821.
   PubMed Web of Science ®Google Scholar
• Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med. 2017;376(7):605–607.
   PubMed Web of Science ®Google Scholar
• Seth P, Scholl L, Rudd RA, et al. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. Am J Transplant. 2018;18(6):1556–1568.
   Web of Science ®Google Scholar
• Mattson CL, Tanz LJ, Quinn K, et al. Morbidity and mortality weekly report trends and geographic patterns in drug and synthetic opioid overdose deaths-United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202–207. https://www.cdc.gov/nchs/data/nvsr/nvsr61/
   PubMed Web of Science ®Google Scholar
• Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital signs : trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–285.
   PubMed Web of Science ®Google Scholar
• Hoots B, Vivolo-Kantor A, Seth P. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Addiction. 2020;115(5):946–958.
   PubMed Web of Science ®Google Scholar
• Friedman J, Montero F, Bourgois P, et al. Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend. 2022;233:109380.
   PubMedGoogle Scholar
• Ruiz-Colón K, Chavez-Arias C, Díaz-Alcalá JE, et al. Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature. Forensic Sci Int. 2014;240:1–8.
   PubMed Web of Science ®Google Scholar
• Romero TRL, Pacheco DDF, Duarte IDG. Xylazine induced Central antinociception mediated by endogenous opioids and μ-opioid receptor, but not δ-or κ-opioid receptors. Brain Res. 2013;1506:58–63.
   PubMedGoogle Scholar
• Muller AA, Osterhoudt KC, Wingert WE. Heroin: what’s in the mix? Ann Emerg Med. 2007;50(3):352–353.
   PubMedGoogle Scholar
• Torruella RA. Xylazine (veterinary sedative) use in Puerto Rico. Subst Abus Treat Prev Policy. 2011;6(1):2–5.
   PubMedGoogle Scholar
• Reyes JC, Negrón JL, Colón HM, et al. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health. 2012;89(3):519–526.
   PubMed Web of Science ®Google Scholar
• Evans A, Krause M, Leach S, et al. Analysis of drug residue in needle-exchange syringes in Washington, D.C. Forensic Sci Int. 2021;329:111083.
   PubMedGoogle Scholar
• Bowles JM, McDonald K, Maghsoudi N, et al. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Harm Reduct J. 2021;18(1):1–6.
   PubMedGoogle Scholar
• Korn WR, Stone MD, Haviland KL, et al. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021. Clin Chim Acta. 2021;521:151–154. (May):
   PubMed Web of Science ®Google Scholar
• Johnson J, Pizzicato L, Johnson C, et al. Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010–2019. Inj Prev. 2021;27(4):395–398.
   PubMed Web of Science ®Google Scholar
• Nunez J, DeJoseph ME, Gill JR. Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths. Am J Forensic Med Pathol. 2021;42(1):9–11.
   PubMed Web of Science ®Google Scholar
• Kariisa M, Patel P, Smith H, et al. Xylazine detection and involvement in drug overdose deaths - United States, 2019. MMWR Morb Mortal Wkly Rep. 2021;70(37):2019–2021.
   Google Scholar
• Thangada S, Clinton HA, Ali S, et al. Notes from the field : xylazine, a veterinary tranquilizer, identified as an emerging novel substance in drug overdose deaths—Connecticut, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70(37):1303–1304.
   PubMed Web of Science ®Google Scholar
• Chhabra N, Mir M, Hua MJ, et al. Notes from the field: xylazine-related deaths—Cook County, Illinois, 2017–2021. MMWR Morb Mortal Wkly Rep. 2022;71(13):2021–2022.
   Google Scholar
• Toxicology Investigators Consortium. American College of Medical Toxicology Toxicology Invesitgators Consortium (ToxIC). Published 2022. https://www.toxicregistry.org/.
   Google Scholar
• Krotulski AJ, Varnum SJ, Logan BK. Sample mining and data mining: combined real-time and retrospective approaches for the identification of emerging novel psychoactive substances. J Forensic Sci. 2020;65(2):550–562.
   PubMed Web of Science ®Google Scholar
• Arts DGT, De Keizer NF, Scheffer GJ. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc. 2002;9(6):600–611.
   PubMed Web of Science ®Google Scholar
• Hirshon JM, Warner M, Irvin CB, et al. Research using emergency department-related data sets: current status and future directions. Acad Emerg Med. 2009;16(11):1103–1109.
   PubMed Web of Science ®Google Scholar
• Forrester MB. Xylazine exposures reported to Texas poison centers. J Emerg Med. 2016;51(4):389–393.
   PubMed Web of Science ®Google Scholar
• Hoffman RJ. Methylxanthines and selective β2-adrenergic agonists. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank’s toxicologic emergencies. 11th ed. New York: McGraw-Hill Education; 2019. http://accessemergencymedicine.mhmedical.com/content.aspx?aid=1163013735
   Google Scholar
• Spoerke DG, Hall AH, Grimes MJ, et al. Human overdose with the veterinary tranquilizer xylazine. Am J Emerg Med. 1986;4(3):222–224.
   PubMed Web of Science ®Google Scholar
• Smollin CG, Hoffman RS. Cocaine. In: Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS, editors. Goldfrank’s toxicologic emergencies. 11th ed. New York: McGraw-Hill Education; 2019. http://accessemergencymedicine.mhmedical.com/content.aspx?aid=1163018244
   Google Scholar
• Perrone J, Hamilton R, Nelson L, et al. Scopolamine poisoning among heroin users - New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996. J Am Med Assoc. 1996;276(2):92–93.
   Google Scholar
• Phillips KA, Hirsch GA, Epstein DH, et al. Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user. J Gen Intern Med. 2012;27(12):1722–1725.
   PubMedGoogle Scholar
• Fiorentin TR, Krotulski AJ, Martin DM, et al. Detection of cutting agents in drug-positive seized exhibits within the United States. J Forensic Sci. 2019;64(3):888–896.
   PubMed Web of Science ®Google Scholar
• Hieger MA, Emswiler MP, Maskell KF, et al. A case series of clenbuterol toxicity caused by adulterated heroin. J Emerg Med. 2016;51(3):259–261.
   PubMedGoogle Scholar
• Manini A, Labinson RM, Kirrane B, et al. A novel neuromuscular syndrome associated with clenbuterol-tainted heroin. Clin Toxicol (Phila). 2008;46(10):1088–1092.
   PubMed Web of Science ®Google Scholar
• Fogarty MF, Mohr ALA, Papsun DM, et al. Analysis of the illicit opioid U-48800 and related compounds by LC-MS-MS and case series of fatalities involving U-48800. J Anal Toxicol. 2022;46(1):17–24.
   PubMedGoogle Scholar
• Zawilska JB, Kuczyńska K, Kosmal W, et al. Carfentanil – from an animal anesthetic to a deadly illicit drug. Forensic Sci Int. 2021;320:110715.
   PubMedGoogle Scholar
• Seger D, Loden JK. Naloxone reversal of clonidine toxicity: dose, dose, dose. Clin Toxicol (Phila). 2018;56(10):873–879.
   PubMed Web of Science ®Google Scholar